Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,516.70
(
-1.14%
)
US TECH 100
23,153.20
(
-1.53%
)
Dow Jones
46,080.96
(
-0.75%
)
Brent Oil
102.53
(
3.80%
)
Bitcoin
68,928.56
(
-3.33%
)
News Focus
News Focus
Post# of 257293
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Double_Bagel

Send PM Follow Ignore
Followers 14
Posts 898
Boards Moderated 0
Alias Born 03/07/2011

Double_Bagel

Re: DewDiligence post# 192029

Wednesday, 06/03/2015 9:07:18 AM

Wednesday, June 03, 2015 9:07:18 AM

Post# of 257293
HALO helps by converting IV drugs to subcutaneous versions (Roche's Mabthera and Herceptin). Isn't Humira already administered subcutaneously? So, how would it help here? Thanks.

http://www.humirapro.com/Resources/HumiraPen.aspx

ABBV licenses HALO’s rHuPH20 technology for undisclosed products (of which one could be a new formulation of Humira):

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today